Megan Brandt Email

VP, Development, Quality & Regulatory Affairs . Cardionomic

Current Roles

Employees:
29
Revenue:
$7.3M
About
Cardionomic is developing a transformative, minimally invasive neuromodulation therapy addressing a large unmet need in the acute decompensated heart failure (ADHF) population. The company's catheter-based system electrically stimulates select cardiac nerves which increases left ventricular contractility (inotropy) and cardiac output without increasing heart rate or inducing the negative systemic effects seen with pharmacological inotropes. Following multiple animal studies which established the proof of concept, Cardionomic has successfully demonstrated human feasibility of the physiological mechanism behind its device in multiple studies. Cardionomic has an outstanding staff comprised of industry experts and is rapidly progressing towards its pivotal study.
Cardionomic Address
601 Campus Dr
New Brighton, MN
United States
Cardionomic Email

Past Companies

Cardionomic, Inc.Vice President, Development, Quality & Regulatory Affairs
CMB Medical, Inc.President
Metavention, Inc.Sr. Vice President, Clinical & Regulatory Affairs

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.